Tengjun Biotechnology Corp.

Rosen Law Firm, a global investor rights law firm, announces that it is investigating potential securities claims on behalf of shareholders of Tengjun Biotechnology Corp. (OTC: TJBH) resulting from allegations that Tengjun may have issued materially misleading business information to the investing public.

If you purchased Tengjun securities and would like to join the prospective action, please click “Join This Class Action.”

If you purchased Tengjun securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

Details of investigation:

On September 5, 2023, Tengjun announced their previous financial statements on Form 10-K for “the fiscal year ended December 31, 2022, should no longer be relied upon due to accounting methodology errors in such financial statements and that the Board deems it advisable and in the best interests of the Company to restate the financial statements by amending its annual report on Form 10-K for the fiscal year ended December 31, 2022 as soon as reasonably practicable.”

On this news, the price of Tengjun’s American Depository Shares (“ADS”) fell $3.15 per ADS, or 17.64%, to close at $14.71 on September 5, 2023.

Follow us on:
Company Name: Tengjun Biotechnology Corp.
Stock Symbol: TJBH
Class Period: N/A
Court: N/A

Why Rosen Law

The Rosen Law Firm has been ranked among the top 4 law firms each year since 2013 for the number of successful securities class actions on behalf of investors. In 2019 alone, our firm recovered $438 million for investors.

Investors should carefully identify and select experienced counsel with a track record of success leading securities class actions. Often other firms issue press releases about class actions yet do not have comparable experience or resources.

Institutional Shareholders Services ranked the Rosen Law Firm # 1 for the number of securities class action recoveries in 2017.

The Rosen Law Firm represents investors throughout the globe. Our mission is to prosecute securities fraud class actions and protect shareholders’ rights.

Scroll to Top